JP2010507686A5 - - Google Patents

Download PDF

Info

Publication number
JP2010507686A5
JP2010507686A5 JP2009534846A JP2009534846A JP2010507686A5 JP 2010507686 A5 JP2010507686 A5 JP 2010507686A5 JP 2009534846 A JP2009534846 A JP 2009534846A JP 2009534846 A JP2009534846 A JP 2009534846A JP 2010507686 A5 JP2010507686 A5 JP 2010507686A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
photoinitiator compound
tissue
eye
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009534846A
Other languages
English (en)
Japanese (ja)
Other versions
JP5559540B2 (ja
JP2010507686A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/082435 external-priority patent/WO2008052081A2/en
Publication of JP2010507686A publication Critical patent/JP2010507686A/ja
Publication of JP2010507686A5 publication Critical patent/JP2010507686A5/ja
Application granted granted Critical
Publication of JP5559540B2 publication Critical patent/JP5559540B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009534846A 2006-10-24 2007-10-24 体組織の機械的および/または化学的性質に影響を及ぼすための光化学療法 Expired - Fee Related JP5559540B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US85394906P 2006-10-24 2006-10-24
US60/853,949 2006-10-24
US95454107P 2007-08-07 2007-08-07
US60/954,541 2007-08-07
PCT/US2007/082435 WO2008052081A2 (en) 2006-10-24 2007-10-24 Photochemical therapy to affect mechanical and/or chemical properties of body tissue

Publications (3)

Publication Number Publication Date
JP2010507686A JP2010507686A (ja) 2010-03-11
JP2010507686A5 true JP2010507686A5 (https=) 2011-04-21
JP5559540B2 JP5559540B2 (ja) 2014-07-23

Family

ID=39325405

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009534846A Expired - Fee Related JP5559540B2 (ja) 2006-10-24 2007-10-24 体組織の機械的および/または化学的性質に影響を及ぼすための光化学療法

Country Status (5)

Country Link
US (1) US8414911B2 (https=)
JP (1) JP5559540B2 (https=)
KR (2) KR101502632B1 (https=)
SG (1) SG175568A1 (https=)
WO (1) WO2008052081A2 (https=)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100266989A1 (en) 2006-11-09 2010-10-21 Klox Technologies Inc. Teeth whitening compositions and methods
WO2008124009A2 (en) * 2007-04-02 2008-10-16 The Cleveland Clinic Foundation Treating glaucoma
EP2227197A4 (en) * 2007-12-05 2011-06-22 Avedro Inc EYE THERAPY SYSTEM
CZ18420U1 (cs) * 2008-01-25 2008-04-07 Benedík@Jaroslav Prístroj na zjištování kvality a pevnosti cévní steny
WO2009114513A2 (en) * 2008-03-14 2009-09-17 Euclid Systems Corporation Ultraviolet irradiation to treat corneal weakness disorders
GB0816399D0 (en) * 2008-09-09 2008-10-15 Sharma Anant Irradiation treatment
US8366689B2 (en) * 2008-09-30 2013-02-05 Avedro, Inc. Method for making structural changes in corneal fibrils
SI2352488T1 (sl) 2008-11-07 2017-07-31 Klox Technologies Inc. Oksidativni fotoaktiviran sestavek za pomlajevanje kože, ki vsebuje hialuronsko kislino, glukozamin ali alantoin
SG177635A1 (en) 2009-07-17 2012-03-29 Klox Technologies Inc Combination of an oxidant, a photosensitizer and a wound healing agent for oral disinfection and treatment of oral disease
US20110077468A1 (en) * 2009-09-30 2011-03-31 Finger Paul T Drug eluting eyelid speculum
WO2011050164A1 (en) * 2009-10-21 2011-04-28 Avedro, Inc. Eye therapy
DE102010008146B4 (de) 2010-02-12 2022-03-31 Carl Zeiss Meditec Ag Messsystem und Verfahren zum Ermitteln des Innendrucks eines Auges sowie Verfahren und System zum Einstellen des Augeninnendrucks
JP6377906B2 (ja) * 2010-03-19 2018-08-22 アヴェドロ・インコーポレーテッドAvedro,Inc. 眼治療を適用およびモニターするためのシステム
DE102010020194B4 (de) 2010-05-07 2022-09-08 Carl Zeiss Meditec Ag Vorrichtung zur Stabilisierung der Augenhornhaut
US9622911B2 (en) 2010-09-30 2017-04-18 Cxl Ophthalmics, Llc Ophthalmic treatment device, system, and method of use
US20120310141A1 (en) * 2011-05-06 2012-12-06 Kornfield Julia A Light delivery device and related compositions, methods and systems
WO2012162529A1 (en) 2011-05-24 2012-11-29 Avedro, Inc. Systems and methods for reshaping an eye feature
WO2012167260A2 (en) * 2011-06-02 2012-12-06 Avedro, Inc. Systems and methods for monitoring time based photo active agent delivery or photo active marker presence
RU2632439C2 (ru) 2011-08-23 2017-10-04 Йеда Рисерч Энд Дивелопмент Ко., Лтд. Фотосенсибилизаторы на основе (бактерио)хлорофилла для лечения глазных заболеваний и расстройств
WO2013148895A1 (en) 2012-03-29 2013-10-03 Cxl Ophthalmics, Llc Ocular cross-linking system and method for sealing corneal wounds
EP2830627B1 (en) 2012-03-29 2024-05-01 Epion Therapeutics, Inc. Ocular treatment solutions, delivery devices and delivery augmentation methods
ES2986057T3 (es) 2012-03-29 2024-11-08 Epion Therapeutics Inc Composiciones y métodos para tratar o prevenir enfermedades asociadas al estrés oxidativo
US11116841B2 (en) 2012-04-20 2021-09-14 Klox Technologies Inc. Biophotonic compositions, kits and methods
US20130281913A1 (en) 2012-04-20 2013-10-24 Klox Technologies Inc. Biophotonic compositions and methods for providing biophotonic treatment
EP2872081B2 (en) 2012-07-16 2025-07-16 Avedro, Inc. Systems for corneal cross-linking with pulsed light
US20140105832A1 (en) 2012-09-14 2014-04-17 Valeant Pharmaceuticals International, Inc. Compositions and methods for teeth whitening
DE102013004482A1 (de) 2013-03-12 2014-09-18 Carl Zeiss Meditec Ag Vorrichtung und Verfahren zur Stabilisierung der Augenhornhaut
US20140276354A1 (en) 2013-03-14 2014-09-18 Klox Technologies Inc. Biophotonic materials and uses thereof
EP2967986A4 (en) * 2013-03-14 2016-11-16 Cxl Ophthalmics Llc EYE TREATMENT DEVICE, SYSTEM AND METHOD OF USE
US9498114B2 (en) 2013-06-18 2016-11-22 Avedro, Inc. Systems and methods for determining biomechanical properties of the eye for applying treatment
US9498122B2 (en) 2013-06-18 2016-11-22 Avedro, Inc. Systems and methods for determining biomechanical properties of the eye for applying treatment
US10881736B2 (en) 2013-07-03 2021-01-05 Klox Technologies Inc. Biophotonic compositions comprising a chromophore and a gelling agent for treating wounds
US9920147B2 (en) 2013-09-13 2018-03-20 Brandeis University Polymeric materials having active cross-linkers, methods for making them, and use thereof
CA2944201A1 (en) 2014-04-01 2015-10-08 Klox Technologies Inc. Tissue filler compositions and methods of use
KR102545628B1 (ko) 2014-10-27 2023-06-20 아베드로 인코퍼레이티드 눈의 교차-결합 처리를 위한 시스템 및 방법
KR20170077153A (ko) 2014-10-31 2017-07-05 클록스 테크놀로지스 인크. 광활성 섬유 및 직물 매질
WO2016077747A1 (en) 2014-11-13 2016-05-19 Avedro, Inc. Multipass virtually imaged phased array etalon
EP3285704B1 (en) 2015-04-24 2020-11-18 Avedro Inc. Systems for photoactivating a photosensitizer applied to an eye
CN107849265A (zh) 2015-05-14 2018-03-27 加州理工学院 使用上转换纳米颗粒和近红外(nir)光的光可调人工晶状体
US10028657B2 (en) 2015-05-22 2018-07-24 Avedro, Inc. Systems and methods for monitoring cross-linking activity for corneal treatments
KR102706856B1 (ko) 2015-07-21 2024-09-19 아베드로 인코퍼레이티드 광증감제로 눈을 치료하기 위한 시스템 및 방법
KR102149590B1 (ko) 2015-12-03 2020-08-28 아베드로 인코퍼레이티드 마스크 장치로 눈을 치료하기 위한 시스템 및 방법
DE102016208012A1 (de) 2016-05-10 2017-11-16 Carl Zeiss Meditec Ag Augenchirurgisches Verfahren
US10765777B2 (en) 2017-06-28 2020-09-08 California Institute Of Technology Light adjustable intraocular lenses using upconverting core-shell nanoparticles and near infrared (NIR) light
EP4260834B1 (en) 2018-03-05 2025-05-07 Avedro, Inc. System for eye tracking during eye treatment
WO2019173762A1 (en) 2018-03-08 2019-09-12 Avedro, Inc. Micro-devices for treatment of an eye
US12144546B2 (en) 2018-09-19 2024-11-19 Avedro, Inc. Systems and methods for eye tracking during eye treatment
CN113329723A (zh) 2018-09-19 2021-08-31 艾维德洛公司 治疗角膜扩张型疾病的系统和方法
CA3113120A1 (en) 2018-10-09 2020-04-16 Avedro, Inc. Photoactivation systems and methods for corneal cross-linking treatments
US11702546B2 (en) 2018-10-24 2023-07-18 California Institute Of Technology Near-infrared heptamethine dyes for generation of singlet oxygen
CN111140774B (zh) * 2019-01-31 2025-10-14 中国科学院昆明动物研究所 一种可抑制眼轴过度增长的新型光源及其模拟方法、灯具
WO2020176598A1 (en) 2019-02-26 2020-09-03 Avedro, Inc. Systems and methods for cross-linking treatments of an eye
JP6853446B2 (ja) * 2019-02-28 2021-03-31 地方独立行政法人神奈川県立産業技術総合研究所 流動体試料の内部構造観察装置及び内部構造解析システム、流動体試料の内部構造観察方法及び内部構造解析方法、並びにセラミックスの製造方法
US11298263B2 (en) * 2019-07-16 2022-04-12 Jack T. Holladay Method of mitigating myopia development and related instrumentation
US11642244B2 (en) 2019-08-06 2023-05-09 Avedro, Inc. Photoactivation systems and methods for corneal cross-linking treatments
WO2022192237A1 (en) 2021-03-08 2022-09-15 Avedro, Inc. Systems and methods for generating patient-specific corneal cross-linking treatment patterns
DE102021131244A1 (de) * 2021-11-29 2023-06-01 Philipps-Universität Marburg, Körperschaft des öffentlichen Rechts Orts- und zeitaufgelöste Bestimmung der dermalen Penetration von nicht- oder schwachfluoreszierenden Substanzen
WO2025255364A1 (en) * 2024-06-07 2025-12-11 The Regents Of The University Of California Methods and devices for transscleral multiphoton imaging and laser therapy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6161544A (en) * 1998-01-28 2000-12-19 Keratoform, Inc. Methods for accelerated orthokeratology
JP2002058695A (ja) * 1999-09-03 2002-02-26 Carl Zeiss Jena Gmbh 眼の照射方法及び装置
WO2005110397A1 (en) 2004-05-07 2005-11-24 The Regents Of The University Of California Treatment of myopia
US20060276777A1 (en) * 2005-04-08 2006-12-07 Coroneo Minas T Corneal shaping
WO2007001926A2 (en) 2005-06-24 2007-01-04 Hyperbranch Medical Technology, Inc. Low-swelling hydrogel sealants for wound repair

Similar Documents

Publication Publication Date Title
JP2010507686A5 (https=)
Wu et al. Corneal cross-linking: the evolution of treatment for corneal diseases
Kim et al. Laser in situ keratomileusis versus laser-assisted subepithelial keratectomy for the correction of high myopia
US20150359668A1 (en) Light delivery device and related compositions, methods and systems
ES2460578T3 (es) Uso de EDTA+trometamina o de foto-potenciadores, asociados a la riboflavina, para la reticulación de la córnea en el tratamiento del queratocono o de otros trastornos ectásicos de la córnea
US10918719B2 (en) Methods for cross-linking corneal collagen with verteporfin for the treatment of disorders of the eye
Wang et al. Photocurable and Temperature‐Sensitive Bioadhesive Hydrogels for Sutureless Sealing of Full‐Thickness Corneal Wounds
US12194053B2 (en) Compositions and methods for reducing oxidative damage
KR20090082392A (ko) 신체 조직의 물리적 및/또는 화학적 성질에 영향을 주는 광화학적 요법
WO2008008330A3 (en) Deuterated ocular solutions for ltk and other surgical eye procedures
EA200501018A1 (ru) Офтальмологический препарат для профилактики и лечения болезненных состояний глаз
Gkika et al. Corneal collagen cross-linking using riboflavin and ultraviolet-A irradiation: a review of clinical and experimental studies
JP2018513117A5 (https=)
Kymionis et al. An overview of corneal collagen cross-linking (CXL)
Quito et al. Long‐Term Followup of Laser In Situ Keratomileusis for Hyperopia Using a 213 nm Wavelength Solid‐State Laser
CA2582316A1 (en) Use of inhibitors of jun n-terminal kinases for the treatment of glaucomatous retinopathy and ocular diseases
Xu et al. Corneal collagen cross-linking: a review of clinical applications
JPWO2019181967A1 (ja) 非侵襲的角膜又は強膜強化装置
ATE251905T1 (de) Verwendung von ubiquinon q 10 zur vorbeugung und behandlung von postoperativen okularen pathologien
CN110859835B (zh) 丁苯酞在制备治疗角膜损伤药物中的应用
RU2620757C1 (ru) Способ лечения кератоконуса
RU2008107696A (ru) Неинвазивная система доставки лекарственного средства к ткани заднего сегмента глаза с применением твердой композиции
KR20000048671A (ko) 각막 상피하 혼탁 억제제
KR20170057644A (ko) 항균 누점플러그 및 그 제조방법
Li et al. The evaluation of corneal fragility after UVA/riboflavin crosslinking